These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10087319)

  • 21. In vivo effect of PC-SPES on prostate growth and hepatic CYP3A expression in rats.
    Wadsworth T; Poonyagariyagorn H; Sullivan E; Koop D; Roselli CE
    J Pharmacol Exp Ther; 2003 Jul; 306(1):187-94. PubMed ID: 12676889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disseminated intravascular coagulation and PC-SPES: a case report and literature review.
    Lock M; Loblaw DA; Choo R; Imrie K
    Can J Urol; 2001 Aug; 8(4):1326-9. PubMed ID: 11564276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro mechanism of PC SPES.
    Chenn S
    Urology; 2001 Aug; 58(2 Suppl 1):28-35; discussion 38. PubMed ID: 11502443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.
    DiPaola RS; Zhang H; Lambert GH; Meeker R; Licitra E; Rafi MM; Zhu BT; Spaulding H; Goodin S; Toledano MB; Hait WN; Gallo MA
    N Engl J Med; 1998 Sep; 339(12):785-91. PubMed ID: 9738085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PC-SPES: phytotherapy for prostate cancer.
    Pandha HS; Kirby RS
    Lancet; 2002 Jun; 359(9325):2213-5. PubMed ID: 12103281
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of PC-SPES on proliferation and expression of AR/PSA in androgen-responsive LNCaP cells are independent of estradiol.
    Hsieh TC; Xiong W; Traganos F; Darzynkiewicz Z; Wu JM
    Anticancer Res; 2002; 22(4):2051-60. PubMed ID: 12174883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PC-SPES: a herbal therapy for the treatment of hormone refractory prostate cancer.
    Meyer JP; Gillatt DA
    Prostate Cancer Prostatic Dis; 2002; 5(1):13-5. PubMed ID: 15195124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells.
    Ikezoe T; Chen SS; Yang Y; Heber D; Taguchi H; Koeffler HP
    Int J Oncol; 2003 Nov; 23(5):1461-70. PubMed ID: 14532991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PC-SPES: herbal formulation for prostate cancer.
    Marks LS; DiPaola RS; Nelson P; Chen S; Heber D; Belldegrun AS; Lowe FC; Fan J; Leaders FE; Pantuck AJ; Tyler VE
    Urology; 2002 Sep; 60(3):369-75; discussion 376-7. PubMed ID: 12350462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES.
    Hsieh T; Chen SS; Wang X; Wu JM
    Biochem Mol Biol Int; 1997 Jul; 42(3):535-44. PubMed ID: 9247711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
    Bonham M; Arnold H; Montgomery B; Nelson PS
    Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanism of anti-prostate cancer activity of Scutellaria baicalensis extract.
    Ye F; Jiang S; Volshonok H; Wu J; Zhang DY
    Nutr Cancer; 2007; 57(1):100-10. PubMed ID: 17516867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
    Oh WK; Kantoff PW; Weinberg V; Jones G; Rini BI; Derynck MK; Bok R; Smith MR; Bubley GJ; Rosen RT; DiPaola RS; Small EJ
    J Clin Oncol; 2004 Sep; 22(18):3705-12. PubMed ID: 15289492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PC-SPES for treatment of prostate cancer: herbal medicine.
    Yip I; Cudiamat M; Chim D
    Curr Urol Rep; 2003 Jun; 4(3):253-7. PubMed ID: 12756091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PC-SPES and prostate cancer.
    Geliebter J; Mittelman A; Tiwari RK
    J Nutr; 2001 Jan; 131(1):164S-166S. PubMed ID: 11208956
    [No Abstract]   [Full Text] [Related]  

  • 36. Complementary and alternative therapies in prostate cancer.
    Oh WK; Small EJ
    Semin Oncol; 2002 Dec; 29(6):575-84. PubMed ID: 12516040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer and the food supplement, PC-SPES. Minireview.
    Thomson JO; Dzubak P; Hajduch M
    Neoplasma; 2002; 49(2):69-74. PubMed ID: 12088108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PC-SPES--a lesson for future dietary supplement research.
    White J
    J Natl Cancer Inst; 2002 Sep; 94(17):1261-3. PubMed ID: 12208885
    [No Abstract]   [Full Text] [Related]  

  • 40. PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells.
    Lu X; Guo J; Hsieh TC
    Cell Cycle; 2003; 2(1):59-63. PubMed ID: 12695690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.